Beyond Fat Loss: Addressing the Sarcopenia Challenge of Incretin-Based Therapies.
Summary withdrawn
TitrateLab removes an AI-written study summary when it states findings we cannot trace to the study's own record, or when the study falls outside the compounds we track. Read the original record through the link above.
incretin
glp-1ra
gip-agonist
obesity
type-2-diabetes
sarcopenia